Technology | November 11, 2014

Online resources features hundreds of real-life clinical cases, follow-up questions and lectures

MeVis Medical Solutions AG, Lahey Hospital Launch Virtual CT Lung Screening Academy

November 11, 2014 — Lung cancer is the No. 1 cancer killer in the United States, causing more deaths each year than breast, colon, pancreas and prostate cancers combined. The National Lung Screening Trial proved that computed tomography (CT) lung cancer screening (LCS) can reduce deaths due to lung cancer by at least 20 percent in individuals at high risk. The resulting endorsement of LCS by the United States Preventive Services Task Force means that millions of high-risk Americans will be granted insurance coverage for annual LCS beginning in 2015.

“Hundreds of CT lung screening programs will be required throughout the United States to meet this oncoming demand. Organizations providing screening services should consider establishing an internal credentialing process for those radiologists interpreting the exams to ensure they are up-to-date with current guidelines and reporting standards.”, explains Brady McKee M.D., section head, thoracic imaging radiology, Lahey Hospital & Medical Center (LHMC) in Burlington, Mass., and co-founder of the hospital’s “Rescue Lung, Rescue Life” CT lung screening program.

LHMC launched their CT lung screening program in January 2012, and developed Lung-RADS, a lung imaging structured reporting and data system, to interpret and code exams. Lung-RADS helps standardize radiology interpretations and facilitates results communication and tracking, radiologist training, quality control and research. The American College of Radiology subsequently adopted Lung-RADS and recommends its use for CT lung screening exam interpretation, quality metric calculation, and national registry participation.

The new interactive online learning platform was developed by medical software specialists MeVis Medical Solutions AG in Bremen, Germany, and the multidisciplinary Rescue Lung, Rescue Life team at LHMC.

To help radiologists quickly learn to apply Lung-RADS to the wide variety of scenarios which may be encountered over time in a clinical CT lung screening program, LHMC has compiled more than 100 actual clinical cases and matching real radiology reports in the MeVis Online Academy including both negative and positive imaging exams. The MeVis Online Academy simulates a real-world reading environment on regular, consumer-grade computers so users may review exams with all the tools typically available on a diagnostic radiology workstation.

A reporting tool is available to identify findings, create a structured report and give a Lung-RADS overall exam assessment and follow-up recommendation for each case. Users can click on actual findings to get pathologic results where available. In addition to the cases, 50 multiple-choice questions covering Lung-RADS and other CT lung screening topics are available. Results from the cases and the multiple-choice questions are used to generate a report available for individual learners to document their efforts and to present for internal institutional credentialing purpose where applicable.

To prepare for the cases and questions, a comprehensive series of lectures are made available covering a variety of topics including CT lung screening risks and benefits, education campaigns, program initiation and operation, Lung-RADS reporting, radiation considerations and diagnostic interventions. This turns the lung academy at MeVis Online Academy into an effective learning tool not only for radiologists but also for professionals from other associated medical disciplines and for lung screening program managers and affiliated health personnel.

MeVis Online Academy is available, on a per-license basis, to individuals and organizations. Registration and payment is all online and no more complicated to complete than a typical online purchase. This intuitive, Web-based application requires no installation and works on broadband Internet-connected, consumer-grade computers.

“I wish I had had this kind of flexible and powerful learning tool at my disposal when we first started our CT lung screening program”, outlines McKee. “I recommend it to all institutions establishing internal radiologist credentialing standards and any member of the lung screening care team interested in a convenient and comprehensive CT lung screening learning environment.”

For more information: www.mevis.de


Related Content

News | PET-CT

June 19, 2025 — Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research ...

Time June 19, 2025
arrow
News | Lung Imaging

April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...

Time April 17, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | SPECT Imaging

Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...

Time February 05, 2025
arrow
News | Computed Tomography (CT)

Dec. 3, 2024 — During RSNA '24, GE HealthCare announced the 510(k) submission to the U.S. Food and Drug Administration ...

Time December 18, 2024
arrow
News | SPECT Imaging

Dec. 2, 2024 — GE HealthCare has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing ...

Time December 05, 2024
arrow
News | Artificial Intelligence

Sept. 13, 2024 — Bayer Calantic Digital Solutions has announced the availability of a new eBook that addresses how ...

Time September 12, 2024
arrow
News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
Subscribe Now